A United States health worker based in Alaska got an allergic reaction after getting COVID-19 vaccine developed by Pfizer Inc. (PFE) and BioNTech SE (BNTX). This information was announced by public health authorities who said the health worker is in stable condition.
A person with first-hand information on the matter said the reaction occurred minutes after the vaccine had been administered similar to two cases reported in Britain less than a week.
The regulator in Britain said any person with a history of anaphylaxis, or severe allergic reactions to a medicine or food should not get the vaccine developed by Pfizer and BioNTech.
Pfizer claims the vaccine comes with visible warning that appropriate supervision and treatment should be readily available in case of anaphylaxis. The company says it might update its labeling language on the vaccine if need be.
On the other side, U.S. Food and Drug Administration said most Americans with allergies should feel very safe to get the vaccine. According to FDA the only people who should avoid this vaccine are ones who have had severe allergic reactions to vaccines or ingredients in this vaccine.
The Alaskan patient was treated in Alaska’s capital Juneau, director of emergency department in the city, Lindy Jones, said the patient didn’t have any history of allergic reactions.
“The symptoms in the middle-aged patient resolved after being administered with allergy treatment epinephrine,” added Jones.
